Ferrologix

Ferrologix, founded in 2015, is a biotechnology startup specializing in cell separation and cellular therapy. The company’s core mission is to revolutionize cell therapy through its patented digital magnetic sorting technology, known as ratcheting cytometry. This technology leverages ferromagnetic microstructure arrays to manipulate magnetic fields at a microscopic scale, enabling high-efficiency, functionally closed, and rapid cell separation with the purity of Fluorescence-Activated Cell Sorting (FACS). Ferrologix primarily focuses on developing novel biomedical and life sciences tools that enhance the precision and efficiency of cell-based therapies.

Notable figures affiliated with Ferrologix include Dr. Coleman Murray, the inventor of the core technology. The company has attracted significant interest from investors in the biotech sector, contributing to its rapid development and innovation. Key achievements include the successful implementation of their digital magnetic sorting technology in various biomedical applications, setting new standards for cell separation efficiency and purity. Overall, Ferrologix has made a substantial impact on the field of cellular therapy, offering advanced solutions that promise to improve therapeutic outcomes and streamline biomedical research processes.